Overview

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

Status:
RECRUITING

Trial end date:
2027-05-01

Target enrollment:

Participant gender:

Summary

The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia

Phase:

PHASE2

Details

Lead Sponsor:

Boryung Pharmaceutical Co., Ltd